glp-1 osteoporosis Frontiers GLP-1s and bone loss!
Description
perhaps this involves biased activation of GPCRs that control inflammation (like more IL-10 release vs
But the way they are marketed raises uncomfortable questions about the future of health care
Habenular TCF7L2 links nicotine addiction to diabetes
Moreover, emerging therapeutic agents are under investigation
The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar in patients with T2D, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke (Fig
